Literature DB >> 1985294

Central nervous system involvement in Von Hippel-Lindau disease.

M R Filling-Katz1, P L Choyke, E Oldfield, L Charnas, N J Patronas, G M Glenn, M B Gorin, J K Morgan, W M Linehan, B R Seizinger.   

Abstract

Fifty individuals with Von Hippel-Lindau disease (VHL) were studied with gadolinium-enhanced magnetic resonance imaging (MRI) to determine the frequency and distribution of CNS lesions. The associated clinical features were also reviewed. Thirty-six (72%) of the 50 had 1 or more CNS tumors. The most frequently affected sites in the CNS excluding the retina were the cerebellum (52%), spinal cord (44%), and brainstem (18%). New regional predilections for the craniocervical junction and conus medullaris were demonstrated by this study. Forty-one percent of all VHL patients with CNS tumors were neurologically asymptomatic: cerebellar tumors (50%), spinal cord tumors (50%), and brainstem tumors (44%) were often without clinical signs or symptoms. Multiple lesions were common. The mean age of all VHL patients (34.5 years) was similar to the mean age of all CNS VHL patients (34.4 years), suggesting a lack of age association. CNS lesions commonly occurred in the 2nd decade of life. All patients at risk for VHL should be evaluated using gadolinium-enhanced MRI after 10 years of age, although ophthalmic examination should be initiated within the 1st 2 years of life. Enhanced MRI is particularly useful in the detection of CNS tumors in patients with the VHL gene.

Entities:  

Mesh:

Year:  1991        PMID: 1985294     DOI: 10.1212/wnl.41.1.41

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Long-term stability after multilevel cervical laminectomy for spinal cord tumor resection in von Hippel-Lindau disease.

Authors:  Ashok R Asthagiri; Gautam U Mehta; John A Butman; Martin Baggenstos; Edward H Oldfield; Russell R Lonser
Journal:  J Neurosurg Spine       Date:  2011-01-28

Review 2.  Neurology and the kidney.

Authors:  D J Burn; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

3.  Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.

Authors:  C A Jilg; Hartmut P H Neumann; S Gläsker; O Schäfer; C Leiber; P U Ardelt; M Schwardt; W Schultze-Seemann
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Von Hippel - Lindau disease.

Authors:  Sna Muhamad Nor; J Haron
Journal:  Malays Fam Physician       Date:  2017-04-30

Review 5.  Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.

Authors:  Michael Charlesworth; Caroline S Verbeke; Gavin A Falk; Matthew Walsh; Andrew M Smith; Gareth Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

6.  Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease.

Authors:  Kristin Huntoon; Tianxia Wu; J Bradley Elder; John A Butman; Emily Y Chew; W Marston Linehan; Edward H Oldfield; Russell R Lonser
Journal:  J Neurosurg       Date:  2015-10-30       Impact factor: 5.115

7.  Solid haemangioblastomas of the CNS: a review of 17 consecutive cases.

Authors:  Jens Rachinger; Rolf Buslei; Julian Prell; Christian Strauss
Journal:  Neurosurg Rev       Date:  2008-09-20       Impact factor: 3.042

8.  A case of von Hippel-Lindau disease with exudative maculopathy.

Authors:  Basel T Ba Arah
Journal:  Oman J Ophthalmol       Date:  2009-05

9.  Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.

Authors:  Russell R Lonser; John A Butman; Kristin Huntoon; Ashok R Asthagiri; Tianxia Wu; Kamran D Bakhtian; Emily Y Chew; Zhengping Zhuang; W Marston Linehan; Edward H Oldfield
Journal:  J Neurosurg       Date:  2014-02-28       Impact factor: 5.115

10.  Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment.

Authors:  Joon Ho Na; Hyeong Soo Kim; Whan Eoh; Jong Hyun Kim; Jong Soo Kim; Eun-Sang Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.